July 21 (Reuters) - The U.S. Food and Drug Administration has approved Verrica Pharmaceuticals Inc's treatment of a viral skin disease in adults and children aged 2 years and above, the company said on Friday. (Reporting by Khushi Mandowara and Sriparna Roy in Bengaluru; Editing by Shailesh Kuber)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.51 USD | +1.92% | -1.38% | +16.80% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.80% | 354M | |
+38.75% | 728B | |
+33.05% | 603B | |
-6.27% | 360B | |
+18.59% | 332B | |
+1.01% | 279B | |
+16.00% | 244B | |
+8.09% | 207B | |
-5.77% | 205B | |
+6.15% | 164B |
- Stock Market
- Equities
- VRCA Stock
- News Verrica Pharmaceuticals Inc.
- US FDA approves Verrica's skin disease treatment